PR Newswire | Jan 4, 2022 08:03AM EST

Conference

01/04 07:00 CST

Thermo Fisher Scientific to Present at the 40th Annual J.P. Morgan Healthcare Conference WALTHAM, Mass., Jan. 4, 2022

WALTHAM, Mass., Jan. 4, 2022 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 8:15 a.m. (EST). Among other topics, Mr. Casper will provide the company's current perspective on its business and expectations for future financial performance.

You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Media Contact Information: Ron O'BrienThermo Fisher Scientific Phone: 781-622-1242 E-mail: ron.obrien@thermofisher.com

Investor Contact Information: Rafael TejadaThermo Fisher Scientific Phone: 781-622-1356 E-mail: rafael.tejada@thermofisher.com

View original content: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301453254.html

SOURCE Thermo Fisher Scientific